Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-Analysis-Reference-Cited by-同舟云学术

Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-Analysis

Published:2021-09-22 Issue:6 Volume:11 Page:1965-1998
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Fahrbach Kyle,Sarri Grammati,Phillippo David M.,Neupane Binod,Martel Samantha E.,Kiri Sandeep,Reich Kristian

Funder

ucb uk

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

https://link.springer.com/content/pdf/10.1007/s13555-021-00602-z.pdf

Reference111 articles.

1. Mantovani L, Medaglia M, Piacentini P, et al. Burden of moderate-to-severe plaque psoriasis and new therapeutic approaches (secukinumab): an Italian Perspective. Dermatol Ther (Heidelb). 2016;6(2):151–67.

2. Gottlieb A, Korman NJ, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008;58(5):851–64.

3. Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58(5):826–50.

4. Gelfand JM, Troxel AB, Lewis JD, et al. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol. 2007;143(12):1493–9.

5. Smith CH, Anstey AV, Barker JN, et al. British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009. Br J Dermatol. 2009;161(5):987–1019.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of moderate to severe psoriasis with brodalumab—Real‐world evidence from the LIBERO study;Journal of the European Academy of Dermatology and Venereology;2024-04-04

2. An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis;New England Journal of Medicine;2024-02-08

3. Short-term Safety of Dimethyl Fumarate for Psoriasis in Korea;Annals of Dermatology;2024

4. Short-, Mid-, and Long-Term Efficacy of Deucravacitinib Versus Biologics and Nonbiologics for Plaque Psoriasis: A Network Meta-Analysis;Dermatology and Therapy;2023-10-06

5. Comparing Meta-Analyses with ChatGPT in the Evaluation of the Effectiveness and Tolerance of Systemic Therapies in Moderate-to-Severe Plaque Psoriasis;Journal of Clinical Medicine;2023-08-20